title: Pharma Pricing & Market Access Europe 2016--Health Network Communications' Tenth Annual Conference (February 23-25, 2016--London, UK).
abstract: Tighter national budgets and escalating drug prices continue to present challenges for pharmaceutical market access strategies and societal cost of care. As pharmaceutical companies and medical governmental advisory organizations enter tougher negotiations, hospital trusts and other dispensary firms face barriers to receiving the best medical treatment, and as a result patient access is limited. The 2016 HealthNetwork Communications' Pharma Pricing & Market Access Europe meeting brought together pharmaceutical, medical governmental advisory and stakeholders and market access/pricing consultants, to encourage discussions and negotiations into how to improve the drug pricing system and consequential market access strategies while achieving the respective reimbursement and affordability objectives.
authors.affiliation: Thomson Reuters, London, UK. paul.dsouza@thomsonreuters.com.
authors.forename: P
authors.initials: P
authors.lastname: D'Souza
mesh_terms: D002017:Budgets; D003365:Costs and Cost Analysis; D016527:Drug Costs; D004345:Drug Industry; D005060:Europe; D005380:Financing, Government / Q000191:economics; D019981:Health Care Sector; D006801:Humans; D007348:Insurance, Health / Q000191:economics; D008131:London; D017008:Negotiating; D009965:Orphan Drug Production / Q000191:economics; D013222:State Medicine / Q000191:economics; D006113:United Kingdom; D014481:United States